245 research outputs found

    Sources of inaccuracy in photoplethysmography for continuous cardiovascular monitoring

    Get PDF
    Photoplethysmography (PPG) is a low-cost, noninvasive optical technique that uses change in light transmission with changes in blood volume within tissue to provide information for cardiovascular health and fitness. As remote health and wearable medical devices become more prevalent, PPG devices are being developed as part of wearable systems to monitor parameters such as heart rate (HR) that do not require complex analysis of the PPG waveform. However, complex analyses of the PPG waveform yield valuable clinical information, such as: blood pressure, respiratory information, sympathetic nervous system activity, and heart rate variability. Systems aiming to derive such complex parameters do not always account for realistic sources of noise, as testing is performed within controlled parameter spaces. A wearable monitoring tool to be used beyond fitness and heart rate must account for noise sources originating from individual patient variations (e.g., skin tone, obesity, age, and gender), physiology (e.g., respiration, venous pulsation, body site of measurement, and body temperature), and external perturbations of the device itself (e.g., motion artifact, ambient light, and applied pressure to the skin). Here, we present a comprehensive review of the literature that aims to summarize these noise sources for future PPG device development for use in health monitoring

    Conduit Artery Photoplethysmography and its Applications in the Assessment of Hemodynamic Condition

    Get PDF
    Elektroniskā versija nesatur pielikumusPromocijas darbā ir izstrādāta maģistrālo artēriju fotopletizmogrāfijas (APPG) metode hemodinamisko parametru novērtējumam. Pretstatot referentām metodēm, demonstrēta iespēja iegūt arteriālo elasticitāti raksturojošus parametrus, izmantojot APPG signāla formas analīzi (atvasinājuma un signāla formas aproksimācijas parametri) un ar APPG iegūtu pulsa izplatīšanās ātrumu unilaterālā gultnē. Izstrādāta APPG reģistrācijas standartizācija, mērījuma laikā nodrošinot optimālo sensora piespiedienu. Šis paņēmiens validēts ārējās ietekmes (sensora piespiediens) un hemodinamisko stāvokļu (perifērā vaskulārā pretestība) izmaiņās femorālā APPG signālā, identificējot būtiskākos faktorus APPG pielietojumos. Veikta APPG validācija asinsrites fizioloģijas un preklīniskā pētījumā demonstrējot APPG potenciālu pētniecībā un diagnostikā. Izstrādāts pulsa formas parametrizācijas paņēmiens, saistot fizioloģiskās un aproksimācijas modeļa komponentes. Atslēgas vārdi: maģistrālā artērija, fotopletizmogrāfija, arteriālā elasticitāte, metodes standartizācija, pulsa formas kvantifikācija, vazomocija, sepseThe doctoral thesis features the development of a conduit artery photoplethysmography technique (APPG) for the evaluation of hemodynamic parameters. Contrasting referent methods, the work demonstrates the possibility to receive parameters characterizing the arterial stiffness by means of APPG waveform analysis (derivation and waveform approximation parameters) and APPG obtained pulse wave velocity in a unilateral vascular bed. In this work APPG standardization technique was developed providing optimal probe contact pressure conditions. It was validated by altering the external factors (probe contact pressure) and hemodynamic conditions (peripheral vascular resistance) on the femoral APPG waveform identifying the key factors in APPG applications. The APPG validation in blood circulation physiology and a pre-clinical trial was performed demonstrating APPG potential in the extension of applications. An arterial waveform parameterization was developed relating the physiological wave to approximation model components. Keywords: conduit artery, photoplethysmography, arterial stiffness, method standardization, waveform parametrization, vasomotion, sepsi

    Non-invasive vascular assessment using photoplethysmography

    Get PDF
    Photoplethysmography (PPG) has become widely accepted as a valuable clinical tool for performing non-invasive biomedical monitoring. The dominant clinical application of PPG has been pulse oximetry, which uses spectral analysis of the peripheral blood supply to establish haemoglobin saturation. PPG has also found success in screening for venous dysfunction, though to a limited degree. Arterial Disease (AD) is a condition where blood flow in the arteries of the body is reduced,a condition known as ischaernia. Ischaernia can result in pain in the affected areas, such as chest pain for an ischearnic heart, but does not always produce symptoms. The most common form of AD is arteriosclerosis, which affects around 5% of the population over 50 years old. Arteriosclerosis, more commonly known as 'hardening of the arteries' is a condition that results in a gradual thickening, hardening and loss of elasticity in the walls of the arteries, reducing overall blood flow. This thesis investigates the possibility of employing PPG to perform vascular assessment, specifically arterial assessment, in two ways. PPG based perfusion monitoring may allow identification of ischaernia in the periphery. To further investigate this premise, prospective experimental trials are performed, firstly to assess the viability of PPG based perfusion monitoring and culminating in the development of a more objective method for determining ABPI using PPG based vascular assessment. A complex interaction between the heart and the connective vasculature, detected at the measuring site, generates the PPG signal. The haemodynamic properties of the vasculature will affect the shape of the PPG waveform, characterising the PPG signal with the properties of the intermediary vasculature. This thesis investigates the feasibility of deriving quantitative vascular parameters from the PPG signal. A quantitative approach allows direct identification of pathology, simplifying vascular assessment. Both forward and inverse models are developed in order to investigate this topic. Application of the models in prospective experimental trials with both normal subjects and subjects suffering PVD have shown encouraging results. It is concluded that the PPG signal contains information on the connective vasculature of the subject. PPG may be used to perform vascular assessment using either perfusion based techniques, where the magnitude of the PPG signal is of interest, or by directly assessing the connective vasculature using PPG, where the shape of the PPG signal is of interest. it is argued that PPG perfusion based techniques for performing the ABPI diagnosis protocol can offer greater sensitivity to the onset of PAD, compared to more conventional methods. It is speculated that the PPG based ABPI diagnosis protocol could provide enhanced PAD diagnosis, detecting the onset of the disease and allowing a treatmenpt lan to be formed soonert han was possible previously. The determination of quantitative vascular parameters using PPG shape could allow direct vascular diagnosis, reducing subjectivity due to interpretation. The prospective trials investigating PPG shape analysis concentrated on PVD diagnosis, but it is speculated that quantitative PPG shaped based vascular assessment could be a powerful tool in the diagnosis of many vascular based pathological conditions

    Acceleration plethysmogram based biometric identification

    Get PDF
    This paper presents the feasibility study of Acceleration Plethysmogram (APG) based biometric identification system. APG signals are obtained from the second derivative of the Photoplethysmogram (PPG) signal. It has been reported from previous literature that APG signals contain more information as compared to the PPG signal. Thus, in this paper, the robustness and reliability of APG signal as a biometric recognition mechanism will be proven. APG signals of 10 subjects were acquired from the Multiparameter Intelligent Monitoring in Intensive Care II Waveform Database (MIMIC2WDB) which contains PPG signals with a sampling frequency of 125 Hz. The signals were later converted into an APG waveform. Then, discriminating features are extracted from the APG morphology. Finally, these APG samples were classified using commonly known classification techniques to identify individuals. Based on the experimentation results, APG signal when using Bayes Network gives an identification rate of 97.5 percentage as compared to PPG signal of 55 percentage for the same waveform. This outcome suggests the feasibility and robustness of APG signals as a biometric modality as compared to PPG signals

    The 2023 wearable photoplethysmography roadmap

    Get PDF
    Photoplethysmography is a key sensing technology which is used in wearable devices such as smartwatches and fitness trackers. Currently, photoplethysmography sensors are used to monitor physiological parameters including heart rate and heart rhythm, and to track activities like sleep and exercise. Yet, wearable photoplethysmography has potential to provide much more information on health and wellbeing, which could inform clinical decision making. This Roadmap outlines directions for research and development to realise the full potential of wearable photoplethysmography. Experts discuss key topics within the areas of sensor design, signal processing, clinical applications, and research directions. Their perspectives provide valuable guidance to researchers developing wearable photoplethysmography technology

    Pulse transit time measured by photoplethysmography improves the accuracy of heart rate as a surrogate measure of cardiac output, stroke volume and oxygen uptake in response to graded exercise

    Get PDF
    Heart rate (HR) is a valuable and widespread measure for physical training programs, although its description of conditioning is limited to the cardiac response to exercise. More comprehensive measures of exercise adaptation include cardiac output ((Q) over dot), stroke volume (SV) and oxygen uptake ((V) over dotO(2)), but these physiological parameters can be measured only with cumbersome equipment installed in clinical settings. In this work, we explore the ability of pulse transit time (PTT) to represent a valuable pairing with HR for indirectly estimating (Q) over dot, SV and (V) over dotO(2) non-invasively. PTT was measured as the time interval between the peak of the electrocardiographic (ECG) R-wave and the onset of the photoplethysmography (PPG) waveform at the periphery (i.e. fingertip) with a portable sensor. Fifteen healthy young subjects underwent a graded incremental cycling protocol after which HR and PTT were correlated with (Q) over dot, SV and (V) over dotO(2) using linear mixed models. The addition of PTT significantly improved the modeling of (Q) over dot, SV and (V) over dotO(2) at the individual level (R-1(2) = 0.419 for SV, 0.548 for (Q) over dot, and 0.771 for (V) over dotO(2)) compared to predictive models based solely on HR (R-1(2) = 0.379 for SV, 0.503 for (Q) over dot, and 0.745 for (V) over dotO(2)). While challenges in sensitivity and artifact rejection exist, combining PTT with HR holds potential for development of novel wearable sensors that provide exercise assessment largely superior to HR monitors

    Hemodynamic monitor for rapid, cost-effective assessment of peripheral vascular function

    Get PDF
    Worldwide, at least 200 million people are affected by peripheral vascular diseases (PVDs), including peripheral arterial disease (PAD), chronic venous insufficiency (CVI) and deep vein thrombosis (DVT). These diseases have considerable socioeconomic impacts due to their high prevalence, cost of investigation, treatment and their effects on quality of life. PVDs are often undiagnosed with up to 60% of patients with PVD remaining asymptomatic. Early diagnosis is essential for effective treatment and reducing socioeconomic costs, particularly in patients with diabetes where early endovascular treatment can prevent lower extremity amputation. However, available diagnostic methods simply do not meet the needs of clinicians. For example, duplex ultrasound or plethysmography are time-consuming methods, costly and require access to highly trained clinicians. Due to the cost and time requirements of such methods, they are often reserved for symptomatic patients. On the other hand, the Ankle Brachial Index (ABI) test is cheap but has poor sensitivity for those patients with diabetes and the elderly, both growing high-risk populations. There is an urgent need for new diagnostic tools to enable earlier intervention. Researchers at the MARCS Institute have developed a novel hemodynamic monitor platform named HeMo, specifically for the assessment of peripheral blood flow in the leg. This development aimed to provide a fast and low-cost diagnosis of both peripheral arterial disease and chronic venous insufficiency. This work first provides a comprehensive literature review of the existing non-invasive diagnostic devices developed since 1677 to highlight the need of development of a new blood monitoring tool. Second, it presents the simplified circuit of the HeMo device and provides series of pilot experiments with HeMo demonstrating its potential for diagnosis of both peripheral arterial disease and chronic venous insufficiency. Third, it presents a quantitative characterisation of the electrical behaviour of the electro-resistive band sensors with the development of an expansion/contraction simulator rig and using spectral analysis. The characterisation of the electro-resistive band was essential to understand the nonlinear electrical behaviour of such sensors and would be of interest for other users and uses of the electro-resistive band sensors. However, in another perspective this sinusoidal linear stretching movement and the presented method shows an example for the application of the presented rig, highlighting that the same technique could be used for characterisation of similar stretchable sensors. Fourth, it shows data from a healthy population, assessing the performance of HeMo compared to light reflection rheography (LRR sensor-VasoScreen 5000) for the assessment of venous function. Fifth, it presents human study data where the performance of HeMo is compared to photoplethysmography (PPG sensor-VasoScreen 5000) for the evaluation of the arterial function. Overall, the presented work here, steps toward development of the final version of a novel hemodynamic monitoring device, and its validation
    corecore